Interleukin-23: Immunological roles and clinical implications

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 4, 2009, Pages 733-735

  Tan, Zi Yan ^a,c   Bealgey, Kenneth W ^b   Fang, Yong ^a   Gong, Yang Ming ^a,c   Bao, Shisan ^a,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c Institute for Biomedical Research   (Australia)

Author keywords

IBD; IL 12; IL 17; IL 23; Th17

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; CELL DIFFERENTIATION; CELL EXPANSION; CYTOKINE PRODUCTION; DENDRITIC CELL; DNA POLYMORPHISM; ENTERITIS; GASTRITIS; HEART INFARCTION; HELICOBACTER PYLORI; INFLAMMATORY DISEASE; INNATE IMMUNITY; MACROPHAGE; MEMORY T LYMPHOCYTE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PSORIASIS; RHEUMATOID ARTHRITIS; SHORT SURVEY; TH1 CELL; TH17 CELL;

ANIMALS; HUMANS; INFLAMMATION; INTERLEUKIN-23;

HELICOBACTER PYLORI;

EID: 59649083691     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.04.027     Document Type: Short Survey

References (20)

1. Aggarwal S., Ghiladri N., Xie M.H., Sauvage F.J., and Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278 3 (2003) 1910-1914
2. Beadling C., and Slifka M.K. Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27. Arch Immunol Ther Exp 54 1 (2006) 15-24
3. Caruso R., Pallone F., and Monteleone G. Emerging role of IL-23/17 axis in H pylori-associated pathology. World J Gastroenterol 13 42 (2007) 5547-5551
4. Cho J.H., and Weaver C.T. The genetics of inflammatory bowel disease. Gastroenterology 133 4 (2007) 1327-1339
5. de Jong R., Altare F., Haagen I.A., Elferink D.G., Boer T., van Breda Vriesman P.J., et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280 5368 (1998) 1435-1438
6. Ghiladri N., Klajavin N., Chen Q., Lucas S., Gurney A.L., and Sauvage F.J. Compromised humoral and delayed-type hypersensitivity responses in IL-23 deficient mice. J Immunol 172 5 (2004) 2827-2833
7. Hue S., Ahern P., Buonocore S., Kullberg M.C., Cua D.J., McKenzie B.S., et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 203 11 (2006) 2473-2483
8. Iwakura Y., and Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest 116 5 (2006) 1218-1222
9. Kastelein R.A., Hunter C.A., and Cua D.J. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 25 (2007) 221-242
10. Kikly K., Liu L., Na S., and Sedgwick J.D. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr Opin Immunol 18 6 (2006) 670-675
11. Kolls J.K., and Linden A. Interleukin-17 family members and inflammation. Immunity 21 4 (2004) 467-476
12. Langrish C.L., McKenzie B.S., Wilson N.J., de Waal Malefyt R., Kastelein R.A., and Cua D.J. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunnol Rev 202 (2004) 96-105
13. Lankford C.S., and Frucht D.M. A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 73 1 (2003) 49-56
14. Lieberman L.A., Cardillo F., Owyang A.M., Rennick D.M., Cua D.J., Kastelein R.A., et al. IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12. J Immunol 173 3 (2004) 1887-1893
15. McGovern D., and Powrie F. The IL23 axis plays a key role in the pathogenesis of IBD. Gut 56 10 (2007) 1333-1336
16. McKenzie B.S., Kastelein R.A., and Cua D.J. Understanding the IL-23-IL-17 immune pathway. Trends Immunol 27 1 (2006) 17-23
17. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13 5 (2000) 715-725
18. Re F., and Strominger J.L. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 276 40 (2001) 37692-37699
19. Uhlig H.H., McKenzie B.S., Hue S., Thompson C., Joyce-Shaikh B., Stepankova R., Robinson N., Buonocore S., Tlaskalova-Hogenova H., Cua D.J., and Powrie F. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25 (2006) 309-318
20. van de Vosse E., Lichtenauer-Kaligis E.G., van Dissel J.T., and Ottenhoff T.H. Genetic variations in the interleukin-12/interleukin-23 receptor (beta1) chain, and implications for IL-12 and IL-23 receptor structure and function. Immunogenetics 54 12 (2003) 817-829